Intrauterine Cannabis Exposure Affects Fetal Growth Trajectories: The Generation R Study
Abstract Objective Cannabis is the most commonly consumed illicit drug among pregnant women. Intrauterine exposure to cannabis may result in risks for the developing fetus. The importance of intrauterine growth on subsequent psychological and behavioral child development has been demonstrated. This...
Gespeichert in:
| Veröffentlicht in: | Journal of the American Academy of Child and Adolescent Psychiatry 2009-12, Vol.48 (12), p.1173-1181 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1181 |
|---|---|
| container_issue | 12 |
| container_start_page | 1173 |
| container_title | Journal of the American Academy of Child and Adolescent Psychiatry |
| container_volume | 48 |
| creator | El Marroun, Hanan, M.Sc Tiemeier, Henning, Ph.D Steegers, Eric A.P., Ph.D., M.D Jaddoe, Vincent W.V., Ph.D., M.D Hofman, Albert, Ph.D., M.D Verhulst, Frank C., Ph.D., M.D van den Brink, Wim, Ph.D., M.D Huizink, Anja C., Ph.D |
| description | Abstract Objective Cannabis is the most commonly consumed illicit drug among pregnant women. Intrauterine exposure to cannabis may result in risks for the developing fetus. The importance of intrauterine growth on subsequent psychological and behavioral child development has been demonstrated. This study examined the relation between maternal cannabis use and fetal growth until birth in a population-based sample. Method Approximately 7,452 mothers enrolled during pregnancy and provided information on substance use and fetal growth. Fetal growth was determined using ultrasound measures in early, mid-, and late pregnancy. Additionally, birth weight was assessed. Results Maternal cannabis use during pregnancy was associated with growth restriction in mid-and late pregnancy and with lower birth weight. This growth reduction was most pronounced for fetuses exposed to continued maternal cannabis use during pregnancy. Fetal weight in cannabis-exposed fetuses showed a growth reduction of −14.44 g/week (95% confidence interval −22.94 to −5.94, p = .001) and head circumference (−0.21 mm/week, 95% confidence interval −0.42 to 0.02, p = .07), compared with nonexposed fetuses. Maternal cannabis use during pregnancy resulted in more pronounced growth restriction than maternal tobacco use. Paternal cannabis use was not associated with fetal growth restriction. Conclusions Maternal cannabis use, even for a short period, may be associated with several adverse fetal growth trajectories. |
| doi_str_mv | 10.1097/CHI.0b013e3181bfa8ee |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_862604745</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ericid>EJ944765</ericid><els_id>1_s2_0_S0890856709660731</els_id><sourcerecordid>862604745</sourcerecordid><originalsourceid>FETCH-LOGICAL-c622t-d174b57b2a04bc22f2961a1dc01a587470bd1d2c7c8647d38210391fec4aaf943</originalsourceid><addsrcrecordid>eNqFktGKEzEUhoMobq2-wSKDoF51zclkkowXwlK63cqC4FbwLmQyZ9jUaaYmM2rf3gwtFXrhXgVyvpz8yXcIuQR6BbSUH-a3qytaUcgxBwVVYxTiEzKBgslZwUE9JROqSjpThZAX5EWMG0opSKWekwsoVaFkISfk-8r3wQw9BucxmxvvTeVitviz6-IQMLtuGrR9zG6wN222DN3v_iFbB7NJu11wGD9m6wfMlugxmN51Pvua3fdDvX9JnjWmjfjquE7Jt5vFen47u_uyXM2v72ZWMNbPapC8KmTFDOWVZaxhpQADtaVgUkQuaVVDzay0SnBZ54oBzUtIobgxTcnzKXl_6LsL3c8BY6-3LlpsW-OxG6JWggnKJS8S-e6_ZCFzLmT5OMgg50zAePebM3DTDcGn5yaGCZ7ElAniB8iGLsaAjd4FtzVhr4Hq0aROJvW5yXTs9bH3UG2x_nfoqC4Bb4-Aida0TTDeunjiGGOUQ4o6JZcHLim2p_Lic8m5FONjPx3LSdIvh0FH69BbrF1IjnXduceCnjewrfMuRfqBe4ynHwEdmab6fhzKcSZpKQSVOeR_Ad0s2Y4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212643189</pqid></control><display><type>article</type><title>Intrauterine Cannabis Exposure Affects Fetal Growth Trajectories: The Generation R Study</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>El Marroun, Hanan, M.Sc ; Tiemeier, Henning, Ph.D ; Steegers, Eric A.P., Ph.D., M.D ; Jaddoe, Vincent W.V., Ph.D., M.D ; Hofman, Albert, Ph.D., M.D ; Verhulst, Frank C., Ph.D., M.D ; van den Brink, Wim, Ph.D., M.D ; Huizink, Anja C., Ph.D</creator><creatorcontrib>El Marroun, Hanan, M.Sc ; Tiemeier, Henning, Ph.D ; Steegers, Eric A.P., Ph.D., M.D ; Jaddoe, Vincent W.V., Ph.D., M.D ; Hofman, Albert, Ph.D., M.D ; Verhulst, Frank C., Ph.D., M.D ; van den Brink, Wim, Ph.D., M.D ; Huizink, Anja C., Ph.D</creatorcontrib><description>Abstract Objective Cannabis is the most commonly consumed illicit drug among pregnant women. Intrauterine exposure to cannabis may result in risks for the developing fetus. The importance of intrauterine growth on subsequent psychological and behavioral child development has been demonstrated. This study examined the relation between maternal cannabis use and fetal growth until birth in a population-based sample. Method Approximately 7,452 mothers enrolled during pregnancy and provided information on substance use and fetal growth. Fetal growth was determined using ultrasound measures in early, mid-, and late pregnancy. Additionally, birth weight was assessed. Results Maternal cannabis use during pregnancy was associated with growth restriction in mid-and late pregnancy and with lower birth weight. This growth reduction was most pronounced for fetuses exposed to continued maternal cannabis use during pregnancy. Fetal weight in cannabis-exposed fetuses showed a growth reduction of −14.44 g/week (95% confidence interval −22.94 to −5.94, p = .001) and head circumference (−0.21 mm/week, 95% confidence interval −0.42 to 0.02, p = .07), compared with nonexposed fetuses. Maternal cannabis use during pregnancy resulted in more pronounced growth restriction than maternal tobacco use. Paternal cannabis use was not associated with fetal growth restriction. Conclusions Maternal cannabis use, even for a short period, may be associated with several adverse fetal growth trajectories.</description><identifier>ISSN: 0890-8567</identifier><identifier>EISSN: 1527-5418</identifier><identifier>DOI: 10.1097/CHI.0b013e3181bfa8ee</identifier><identifier>PMID: 19858757</identifier><identifier>CODEN: JAAPEE</identifier><language>eng</language><publisher>Maryland Heights, MO: Elsevier Inc</publisher><subject>Adult ; Biological and medical sciences ; Birth weight ; Birth Weight - drug effects ; Body Weight ; Cannabis ; Child clinical studies ; Child Development ; Cohort Studies ; Confidence intervals ; Correlation ; Dronabinol - toxicity ; Drug use ; Evaluation Methods ; Feedback (Response) ; Female ; Females ; Fetal Development - drug effects ; Fetal growth ; Fetal Growth Retardation - chemically induced ; Fetal Growth Retardation - diagnostic imaging ; Fetuses ; Gestational Age ; Humans ; Infant, Newborn ; Intervals ; intrauterine cannabis exposure ; longitudinal population cohort ; Male ; Marijuana ; Marijuana Abuse - diagnostic imaging ; Marijuana Abuse - physiopathology ; Maternal & child health ; Maternal Exposure - adverse effects ; Medical sciences ; Netherlands ; Paternal Exposure - adverse effects ; Pediatrics ; Physical Development ; Pregnancy ; Pregnant women ; Prenatal Exposure Delayed Effects - diagnostic imaging ; Prenatal Exposure Delayed Effects - physiopathology ; Prenatal Influences ; Prospective Studies ; Psychiatry ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychotropic Drugs - toxicity ; Science Education ; Ultrasonic imaging ; Ultrasonography, Prenatal ; ultrasound measurements</subject><ispartof>Journal of the American Academy of Child and Adolescent Psychiatry, 2009-12, Vol.48 (12), p.1173-1181</ispartof><rights>American Academy of Child and Adolescent Psychiatry</rights><rights>2009 American Academy of Child and Adolescent Psychiatry</rights><rights>2015 INIST-CNRS</rights><rights>Copyright Lippincott Williams & Wilkins Dec 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c622t-d174b57b2a04bc22f2961a1dc01a587470bd1d2c7c8647d38210391fec4aaf943</citedby><cites>FETCH-LOGICAL-c622t-d174b57b2a04bc22f2961a1dc01a587470bd1d2c7c8647d38210391fec4aaf943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0890856709660731$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,30976,30977,65306</link.rule.ids><backlink>$$Uhttp://eric.ed.gov/ERICWebPortal/detail?accno=EJ944765$$DView record in ERIC$$Hfree_for_read</backlink><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22204121$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19858757$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>El Marroun, Hanan, M.Sc</creatorcontrib><creatorcontrib>Tiemeier, Henning, Ph.D</creatorcontrib><creatorcontrib>Steegers, Eric A.P., Ph.D., M.D</creatorcontrib><creatorcontrib>Jaddoe, Vincent W.V., Ph.D., M.D</creatorcontrib><creatorcontrib>Hofman, Albert, Ph.D., M.D</creatorcontrib><creatorcontrib>Verhulst, Frank C., Ph.D., M.D</creatorcontrib><creatorcontrib>van den Brink, Wim, Ph.D., M.D</creatorcontrib><creatorcontrib>Huizink, Anja C., Ph.D</creatorcontrib><title>Intrauterine Cannabis Exposure Affects Fetal Growth Trajectories: The Generation R Study</title><title>Journal of the American Academy of Child and Adolescent Psychiatry</title><addtitle>J Am Acad Child Adolesc Psychiatry</addtitle><description>Abstract Objective Cannabis is the most commonly consumed illicit drug among pregnant women. Intrauterine exposure to cannabis may result in risks for the developing fetus. The importance of intrauterine growth on subsequent psychological and behavioral child development has been demonstrated. This study examined the relation between maternal cannabis use and fetal growth until birth in a population-based sample. Method Approximately 7,452 mothers enrolled during pregnancy and provided information on substance use and fetal growth. Fetal growth was determined using ultrasound measures in early, mid-, and late pregnancy. Additionally, birth weight was assessed. Results Maternal cannabis use during pregnancy was associated with growth restriction in mid-and late pregnancy and with lower birth weight. This growth reduction was most pronounced for fetuses exposed to continued maternal cannabis use during pregnancy. Fetal weight in cannabis-exposed fetuses showed a growth reduction of −14.44 g/week (95% confidence interval −22.94 to −5.94, p = .001) and head circumference (−0.21 mm/week, 95% confidence interval −0.42 to 0.02, p = .07), compared with nonexposed fetuses. Maternal cannabis use during pregnancy resulted in more pronounced growth restriction than maternal tobacco use. Paternal cannabis use was not associated with fetal growth restriction. Conclusions Maternal cannabis use, even for a short period, may be associated with several adverse fetal growth trajectories.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Birth weight</subject><subject>Birth Weight - drug effects</subject><subject>Body Weight</subject><subject>Cannabis</subject><subject>Child clinical studies</subject><subject>Child Development</subject><subject>Cohort Studies</subject><subject>Confidence intervals</subject><subject>Correlation</subject><subject>Dronabinol - toxicity</subject><subject>Drug use</subject><subject>Evaluation Methods</subject><subject>Feedback (Response)</subject><subject>Female</subject><subject>Females</subject><subject>Fetal Development - drug effects</subject><subject>Fetal growth</subject><subject>Fetal Growth Retardation - chemically induced</subject><subject>Fetal Growth Retardation - diagnostic imaging</subject><subject>Fetuses</subject><subject>Gestational Age</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Intervals</subject><subject>intrauterine cannabis exposure</subject><subject>longitudinal population cohort</subject><subject>Male</subject><subject>Marijuana</subject><subject>Marijuana Abuse - diagnostic imaging</subject><subject>Marijuana Abuse - physiopathology</subject><subject>Maternal & child health</subject><subject>Maternal Exposure - adverse effects</subject><subject>Medical sciences</subject><subject>Netherlands</subject><subject>Paternal Exposure - adverse effects</subject><subject>Pediatrics</subject><subject>Physical Development</subject><subject>Pregnancy</subject><subject>Pregnant women</subject><subject>Prenatal Exposure Delayed Effects - diagnostic imaging</subject><subject>Prenatal Exposure Delayed Effects - physiopathology</subject><subject>Prenatal Influences</subject><subject>Prospective Studies</subject><subject>Psychiatry</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychotropic Drugs - toxicity</subject><subject>Science Education</subject><subject>Ultrasonic imaging</subject><subject>Ultrasonography, Prenatal</subject><subject>ultrasound measurements</subject><issn>0890-8567</issn><issn>1527-5418</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqFktGKEzEUhoMobq2-wSKDoF51zclkkowXwlK63cqC4FbwLmQyZ9jUaaYmM2rf3gwtFXrhXgVyvpz8yXcIuQR6BbSUH-a3qytaUcgxBwVVYxTiEzKBgslZwUE9JROqSjpThZAX5EWMG0opSKWekwsoVaFkISfk-8r3wQw9BucxmxvvTeVitviz6-IQMLtuGrR9zG6wN222DN3v_iFbB7NJu11wGD9m6wfMlugxmN51Pvua3fdDvX9JnjWmjfjquE7Jt5vFen47u_uyXM2v72ZWMNbPapC8KmTFDOWVZaxhpQADtaVgUkQuaVVDzay0SnBZ54oBzUtIobgxTcnzKXl_6LsL3c8BY6-3LlpsW-OxG6JWggnKJS8S-e6_ZCFzLmT5OMgg50zAePebM3DTDcGn5yaGCZ7ElAniB8iGLsaAjd4FtzVhr4Hq0aROJvW5yXTs9bH3UG2x_nfoqC4Bb4-Aida0TTDeunjiGGOUQ4o6JZcHLim2p_Lic8m5FONjPx3LSdIvh0FH69BbrF1IjnXduceCnjewrfMuRfqBe4ynHwEdmab6fhzKcSZpKQSVOeR_Ad0s2Y4</recordid><startdate>20091201</startdate><enddate>20091201</enddate><creator>El Marroun, Hanan, M.Sc</creator><creator>Tiemeier, Henning, Ph.D</creator><creator>Steegers, Eric A.P., Ph.D., M.D</creator><creator>Jaddoe, Vincent W.V., Ph.D., M.D</creator><creator>Hofman, Albert, Ph.D., M.D</creator><creator>Verhulst, Frank C., Ph.D., M.D</creator><creator>van den Brink, Wim, Ph.D., M.D</creator><creator>Huizink, Anja C., Ph.D</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier BV</general><scope>7SW</scope><scope>BJH</scope><scope>BNH</scope><scope>BNI</scope><scope>BNJ</scope><scope>BNO</scope><scope>ERI</scope><scope>PET</scope><scope>REK</scope><scope>WWN</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20091201</creationdate><title>Intrauterine Cannabis Exposure Affects Fetal Growth Trajectories: The Generation R Study</title><author>El Marroun, Hanan, M.Sc ; Tiemeier, Henning, Ph.D ; Steegers, Eric A.P., Ph.D., M.D ; Jaddoe, Vincent W.V., Ph.D., M.D ; Hofman, Albert, Ph.D., M.D ; Verhulst, Frank C., Ph.D., M.D ; van den Brink, Wim, Ph.D., M.D ; Huizink, Anja C., Ph.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c622t-d174b57b2a04bc22f2961a1dc01a587470bd1d2c7c8647d38210391fec4aaf943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Birth weight</topic><topic>Birth Weight - drug effects</topic><topic>Body Weight</topic><topic>Cannabis</topic><topic>Child clinical studies</topic><topic>Child Development</topic><topic>Cohort Studies</topic><topic>Confidence intervals</topic><topic>Correlation</topic><topic>Dronabinol - toxicity</topic><topic>Drug use</topic><topic>Evaluation Methods</topic><topic>Feedback (Response)</topic><topic>Female</topic><topic>Females</topic><topic>Fetal Development - drug effects</topic><topic>Fetal growth</topic><topic>Fetal Growth Retardation - chemically induced</topic><topic>Fetal Growth Retardation - diagnostic imaging</topic><topic>Fetuses</topic><topic>Gestational Age</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Intervals</topic><topic>intrauterine cannabis exposure</topic><topic>longitudinal population cohort</topic><topic>Male</topic><topic>Marijuana</topic><topic>Marijuana Abuse - diagnostic imaging</topic><topic>Marijuana Abuse - physiopathology</topic><topic>Maternal & child health</topic><topic>Maternal Exposure - adverse effects</topic><topic>Medical sciences</topic><topic>Netherlands</topic><topic>Paternal Exposure - adverse effects</topic><topic>Pediatrics</topic><topic>Physical Development</topic><topic>Pregnancy</topic><topic>Pregnant women</topic><topic>Prenatal Exposure Delayed Effects - diagnostic imaging</topic><topic>Prenatal Exposure Delayed Effects - physiopathology</topic><topic>Prenatal Influences</topic><topic>Prospective Studies</topic><topic>Psychiatry</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychotropic Drugs - toxicity</topic><topic>Science Education</topic><topic>Ultrasonic imaging</topic><topic>Ultrasonography, Prenatal</topic><topic>ultrasound measurements</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>El Marroun, Hanan, M.Sc</creatorcontrib><creatorcontrib>Tiemeier, Henning, Ph.D</creatorcontrib><creatorcontrib>Steegers, Eric A.P., Ph.D., M.D</creatorcontrib><creatorcontrib>Jaddoe, Vincent W.V., Ph.D., M.D</creatorcontrib><creatorcontrib>Hofman, Albert, Ph.D., M.D</creatorcontrib><creatorcontrib>Verhulst, Frank C., Ph.D., M.D</creatorcontrib><creatorcontrib>van den Brink, Wim, Ph.D., M.D</creatorcontrib><creatorcontrib>Huizink, Anja C., Ph.D</creatorcontrib><collection>ERIC</collection><collection>ERIC (Ovid)</collection><collection>ERIC</collection><collection>ERIC</collection><collection>ERIC (Legacy Platform)</collection><collection>ERIC( SilverPlatter )</collection><collection>ERIC</collection><collection>ERIC PlusText (Legacy Platform)</collection><collection>Education Resources Information Center (ERIC)</collection><collection>ERIC</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Child and Adolescent Psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>El Marroun, Hanan, M.Sc</au><au>Tiemeier, Henning, Ph.D</au><au>Steegers, Eric A.P., Ph.D., M.D</au><au>Jaddoe, Vincent W.V., Ph.D., M.D</au><au>Hofman, Albert, Ph.D., M.D</au><au>Verhulst, Frank C., Ph.D., M.D</au><au>van den Brink, Wim, Ph.D., M.D</au><au>Huizink, Anja C., Ph.D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><ericid>EJ944765</ericid><atitle>Intrauterine Cannabis Exposure Affects Fetal Growth Trajectories: The Generation R Study</atitle><jtitle>Journal of the American Academy of Child and Adolescent Psychiatry</jtitle><addtitle>J Am Acad Child Adolesc Psychiatry</addtitle><date>2009-12-01</date><risdate>2009</risdate><volume>48</volume><issue>12</issue><spage>1173</spage><epage>1181</epage><pages>1173-1181</pages><issn>0890-8567</issn><eissn>1527-5418</eissn><coden>JAAPEE</coden><abstract>Abstract Objective Cannabis is the most commonly consumed illicit drug among pregnant women. Intrauterine exposure to cannabis may result in risks for the developing fetus. The importance of intrauterine growth on subsequent psychological and behavioral child development has been demonstrated. This study examined the relation between maternal cannabis use and fetal growth until birth in a population-based sample. Method Approximately 7,452 mothers enrolled during pregnancy and provided information on substance use and fetal growth. Fetal growth was determined using ultrasound measures in early, mid-, and late pregnancy. Additionally, birth weight was assessed. Results Maternal cannabis use during pregnancy was associated with growth restriction in mid-and late pregnancy and with lower birth weight. This growth reduction was most pronounced for fetuses exposed to continued maternal cannabis use during pregnancy. Fetal weight in cannabis-exposed fetuses showed a growth reduction of −14.44 g/week (95% confidence interval −22.94 to −5.94, p = .001) and head circumference (−0.21 mm/week, 95% confidence interval −0.42 to 0.02, p = .07), compared with nonexposed fetuses. Maternal cannabis use during pregnancy resulted in more pronounced growth restriction than maternal tobacco use. Paternal cannabis use was not associated with fetal growth restriction. Conclusions Maternal cannabis use, even for a short period, may be associated with several adverse fetal growth trajectories.</abstract><cop>Maryland Heights, MO</cop><pub>Elsevier Inc</pub><pmid>19858757</pmid><doi>10.1097/CHI.0b013e3181bfa8ee</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0890-8567 |
| ispartof | Journal of the American Academy of Child and Adolescent Psychiatry, 2009-12, Vol.48 (12), p.1173-1181 |
| issn | 0890-8567 1527-5418 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_862604745 |
| source | Applied Social Sciences Index & Abstracts (ASSIA); MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adult Biological and medical sciences Birth weight Birth Weight - drug effects Body Weight Cannabis Child clinical studies Child Development Cohort Studies Confidence intervals Correlation Dronabinol - toxicity Drug use Evaluation Methods Feedback (Response) Female Females Fetal Development - drug effects Fetal growth Fetal Growth Retardation - chemically induced Fetal Growth Retardation - diagnostic imaging Fetuses Gestational Age Humans Infant, Newborn Intervals intrauterine cannabis exposure longitudinal population cohort Male Marijuana Marijuana Abuse - diagnostic imaging Marijuana Abuse - physiopathology Maternal & child health Maternal Exposure - adverse effects Medical sciences Netherlands Paternal Exposure - adverse effects Pediatrics Physical Development Pregnancy Pregnant women Prenatal Exposure Delayed Effects - diagnostic imaging Prenatal Exposure Delayed Effects - physiopathology Prenatal Influences Prospective Studies Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychotropic Drugs - toxicity Science Education Ultrasonic imaging Ultrasonography, Prenatal ultrasound measurements |
| title | Intrauterine Cannabis Exposure Affects Fetal Growth Trajectories: The Generation R Study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T15%3A50%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intrauterine%20Cannabis%20Exposure%20Affects%20Fetal%20Growth%20Trajectories:%20The%20Generation%20R%20Study&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Child%20and%20Adolescent%20Psychiatry&rft.au=El%20Marroun,%20Hanan,%20M.Sc&rft.date=2009-12-01&rft.volume=48&rft.issue=12&rft.spage=1173&rft.epage=1181&rft.pages=1173-1181&rft.issn=0890-8567&rft.eissn=1527-5418&rft.coden=JAAPEE&rft_id=info:doi/10.1097/CHI.0b013e3181bfa8ee&rft_dat=%3Cproquest_cross%3E862604745%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=212643189&rft_id=info:pmid/19858757&rft_ericid=EJ944765&rft_els_id=1_s2_0_S0890856709660731&rfr_iscdi=true |